A few of our favorite Beyond The Printed Page articles from 2018.
How the interview with J&J’s Joaquin Duato originated over a year ago, and how the company is dealing with a recent negative article in the media.
Joaquin Duato, vice chairman of J&J’s executive committee, discusses how the company’s partnering and innovation-building model has evolved — and why.
Day 3 of the Netherlands’ biopharma press tour begins with presentations at the Utrecht Science Park (USP).
Rob Wright provides insight into The Board Meeting West, a life sciences industry event for high-level biopharmaceutical executives serving on corporate boards, or hoping to do so in the near future.
Rob Wright provides a bit of his perspective on the 37th Annual J.P. Morgan Healthcare Conference.
“Making sure we had the money for staff and activities to build the business for the long-term was a key initial step,” explains Dr. Helen Torley, CEO of Halozyme Therapeutics.
What measures should we use to reflect on the 2018 biopharma industry? One metric could be the number of novel drug approvals.
Rob Wright shares experiences from day two of recent press tour of the Netherlands’ biopharmaceutical industry.